EDWARD L AUEN

Allopathic & Osteopathic Physicians|Internal Medicine MODESTO, CA NPI 1962464602

General Payments — all program years on this page

$1,146.52

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 52
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $419.02 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $419.0221

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $227.043
2019 $11.401
2021 $46.294
2022 $65.684
2023 $377.0919
2024 $419.0221

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1080601086 Verity Pharmaceuticals Inc. $23.57 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080601090 Verity Pharmaceuticals Inc. $17.72 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080601094 Verity Pharmaceuticals Inc. $13.92 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080601098 Verity Pharmaceuticals Inc. $16.11 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096642609 Novo Nordisk Inc $27.94 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100562112 RGH Enterprises LLC $23.30 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104464830 AstraZeneca Pharmaceuticals LP $20.05 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105634576 AstraZeneca Pharmaceuticals LP $19.88 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116288923 GlaxoSmithKline, LLC. $17.15 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117746321 Corcept Therapeutics $13.67 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118252248 Boehringer Ingelheim Pharmaceuticals, Inc. $17.89 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118252250 Boehringer Ingelheim Pharmaceuticals, Inc. $24.35 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131491200 PFIZER INC. $19.75 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134966209 Lilly USA, LLC $15.62 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134966211 Lilly USA, LLC $24.64 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136154868 Lilly USA, LLC $19.82 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139292032 Astellas Pharma US Inc $21.62 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139315188 Astellas Pharma US Inc $25.38 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144593282 Xeris Pharmaceuticals, Inc. $15.75 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146447935 Antares Pharma, Inc. $20.42 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151036777 Phathom Pharmaceuticals, Inc. $20.47 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.